search
Back to results

Comparing Different Delivery Systems of Continuous Positive Airway Pressure in Neonates

Primary Purpose

Prematurity, Respiratory Distress Syndrome

Status
Recruiting
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
RAM cannula ventilator CPAP
Occlusive interface bubble CPAP
Sponsored by
Massachusetts General Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional basic science trial for Prematurity focused on measuring continuous positive airway pressure

Eligibility Criteria

12 Hours - 36 Hours (Child)All SexesDoes not accept healthy volunteers

Inclusion Criteria: medically stable neonates born >32 0/7 weeks and < 37 0/7 weeks gestational age, with birth weights > 1500 grams, are chronologically 12-36 hours old, and are receiving RAM cannula ventilator CPAP with positive end expiratory pressure (PEEP) between 5-6 cm water (H2O) and Fraction of inspired oxygen (FiO2) < 0.3 for the suspected diagnosis of respiratory distress syndrome Exclusion Criteria: neonates with congenital anomalies that potentially will affect respiratory physiology, for example hypoplastic lungs or gastroschisis. neonates with contraindications for wearing an occlusive interface, for example epidermolysis bullosa which may have risk of worsening skin integrity at the pressure points of the occlusive interface, or a known small air leak that may potentially develop into a large pneumothorax. neonates with contraindications for placement of esophageal balloon manometry, for example hypoglycemia managed with extended feeding times greater than 30 minutes. neonates with contraindications for electrical impedance tomography, for example inability to ensure contact of the electrodes on the belt with the skin on the circumference of the chest due to presence of a chest tube dressing.

Sites / Locations

  • Massachusetts General HospitalRecruiting

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm 4

Arm Type

Experimental

Experimental

Active Comparator

Active Comparator

Arm Label

Randomization to CPAP with higher change of impedance as measured by EIT. "Arm A-1"

Randomization to CPAP with higher change of impedance as measured by EIT. "Arm A-2"

Randomization to standard of care - a 'one size fits all' approach. "Arm B-1"

Randomization to standard of care - a 'one size fits all' approach. "Arm B-2"

Arm Description

After comparing change of impedance as measured by electrical impedance tomography while supported on RAM cannula ventilator CPAP versus occlusive interface bubble CPAP, the participants in this arm are placed on the CPAP that had a greater change of impedance (or less pressure rate product as measured by the esophageal balloon manometry if the change of impedance between the two CPAP modalities are clinically similar). In this Arm A-1, these subjects had higher change in impedance while supported on RAM cannula ventilator CPAP

After comparing change of impedance as measured by electrical impedance tomography while supported on RAM cannula ventilator CPAP versus occlusive interface bubble CPAP, the participants in this arm are placed on the CPAP that had a greater change of impedance (or less pressure rate product as measured by the esophageal balloon manometry if the change of impedance between the two CPAP modalities are clinically similar). In this Arm A-2, these subjects had higher change in impedance while supported on occlusive mask bubble CPAP

Currently, the approach to which CPAP modality is chosen for these newborns is defaulted to the preferred CPAP of the Neonatal Intensive Care Unit (NICU) where the newborn is hospitalized. In this Arm B-1, these subjects are randomized 1:1 to RAM cannula ventilator CPAP

Currently, the approach to which CPAP modality is chosen for these newborns is defaulted to the preferred CPAP of the NICU where the newborn is hospitalized. In this Arm B-2, these subjects are randomized 1:1 to occlusive mask bubble CPAP

Outcomes

Primary Outcome Measures

change in electrical impedance
change in average electrical impedance with each CPAP delivery modality
duration of CPAP treatment
compare groups Arm A-1, A-2 vs Arm B-1, B2; Compare groups Arm A-1, B-1 vs Arm A-2, B-2

Secondary Outcome Measures

lung physiology measurements (exploratory measures during this pilot study, in preparation for a powered larger trial) change in end expiratory lung impedance
change in end expiratory lung impedance (arbitrary units)
lung physiology measurements (exploratory measures during this pilot study, in preparation for a powered larger trial) vascular pulsatility
vascular pulsatility (arbitrary units)
lung physiology measurements (exploratory measures during this pilot study, in preparation for a powered larger trial) tidal volume
tidal volume (in milliliters) per weight (in kilograms)
lung physiology measurements (exploratory measures during this pilot study, in preparation for a powered larger trial) change in minute ventilation
change in minute ventilation (mL/minute)
lung physiology measurements (exploratory measures during this pilot study, in preparation for a powered larger trial) change in dynamic compliance
change in dynamic compliance (mL/cmH2O)
lung physiology measurements (exploratory measures during this pilot study, in preparation for a powered larger trial) Respiratory rate
Respiratory rate (breaths per minute)
lung physiology measurements (exploratory measures during this pilot study, in preparation for a powered larger trial) Oxygen saturation
Oxygen saturation (percentage)
lung physiology measurements (exploratory measures during this pilot study, in preparation for a powered larger trial) Abdominal circumference
Abdominal circumference (cm)
lung physiology measurements (exploratory measures during this pilot study, in preparation for a powered larger trial) esophageal pressure change
esophageal pressure change (mm Hg)
lung physiology measurements (exploratory measures during this pilot study, in preparation for a powered larger trial) end expiratory pressure
end expiratory pressure via esophageal balloon manometry (mm Hg)
lung physiology measurements (exploratory measures during this pilot study, in preparation for a powered larger trial) pressure rate product
pressure rate product (cm H2O / min)
clinical outcomes of different CPAP modalities (exploratory measures during this pilot study, in preparation for a powered larger trial) Frequency of deviation
frequency of deviation from assigned CPAP treatment (percentage)
clinical outcomes of different CPAP modalities (exploratory measures during this pilot study, in preparation for a powered larger trial) frequency of exogenous surfactant administration
frequency of exogenous surfactant administration (percentage)
clinical outcomes of different CPAP modalities (exploratory measures during this pilot study, in preparation for a powered larger trial)
respiratory support settings if deviated from assigned CPAP treatment (percentage)

Full Information

First Posted
August 29, 2023
Last Updated
October 17, 2023
Sponsor
Massachusetts General Hospital
search

1. Study Identification

Unique Protocol Identification Number
NCT06038565
Brief Title
Comparing Different Delivery Systems of Continuous Positive Airway Pressure in Neonates
Official Title
Comparing Regional Ventilation in Neonates With Different Delivery Systems of Continuous Positive Airway Pressure
Study Type
Interventional

2. Study Status

Record Verification Date
October 2023
Overall Recruitment Status
Recruiting
Study Start Date
October 18, 2023 (Actual)
Primary Completion Date
October 18, 2024 (Anticipated)
Study Completion Date
October 18, 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Massachusetts General Hospital

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The goal of this clinical trial is to compare late preterm newborn lung physiology when supported with different continuous positive airway pressure (CPAP) devices. The main questions it aims to answer are: Which CPAP modality provides better breathing support in newborns with respiratory distress syndrome who are greater than 32 weeks gestational age? Does the lung physiology data predict the CPAP modality that will result in a shorter CPAP treatment duration? Participants will wear a belt of electrodes on their chest (electrical impedance tomography) and have an esophageal balloon manometry measure lung physiology data for 2.5 hours while switching CPAP devices. Participants will then be randomly assigned to a CPAP device to support their breathing until they recover from respiratory distress syndrome.
Detailed Description
Across centers, there is a variation in standard of care for the preferred device and interface to deliver continuous positive airway pressure (CPAP) to support neonatal functional residual capacity. CPAP, a type of noninvasive respiratory support, is commonly delivered to neonates by mechanical ventilators or underwater bubble devices (bubble CPAP). Variation also exists with the tubing used to deliver CPAP. One commonly used nasal interface is the RAM cannula (Neotech, Valencia, CA), made of a soft material with thin tubing walls and is designed to provide 60-80% occlusion of the nares. This contrasts with the occlusive interface intended to provide complete seal. To provide evidence for standardization of CPAP delivery, clinical trials are needed to assess which modality of CPAP delivery is optimal for neonates with respiratory distress syndrome who are > 32 weeks and <37 weeks gestational age, an understudied population. The investigators propose to use electrical impedance tomography (EIT) paired with esophageal balloon manometry to assess neonatal lung physiology when supported with different modalities of CPAP. Furthermore, participants will be randomly assigned to A) physiology based CPAP vs B) one size fits all approach. The subjects will remain on the assigned modality of CPAP for the remainder of their respiratory distress syndrome treatment, and researchers will track which modality of CPAP results in a shorter CPAP treatment period and if this is expected based on the lung physiology data collected.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Prematurity, Respiratory Distress Syndrome
Keywords
continuous positive airway pressure

7. Study Design

Primary Purpose
Basic Science
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Lung physiology measurements with electrical impedance tomography and esophageal manometry will be collected while the participant is supported with RAM cannula ventilator CPAP followed by occlusive interface ventilator CPAP followed by occlusive interface bubble CPAP. A 1:1 block randomization of either A) physiology-based CPAP or B) one size fits all CPAP of either RAM cannula ventilator CPAP or occlusive interface bubble CPAP will be assigned to the participant. Arm B is further randomized 1:1 to either RAM cannula ventilator CPAP or occlusive interface bubble CPAP. The duration of CPAP treatment will be compared between the two arms (precision medicine approach vs standard of care) as well as compare each device and whether the physiology data would have predicted the CPAP device would have resulted in a shorter treatment period.
Masking
ParticipantCare ProviderOutcomes Assessor
Masking Description
Given the nature of CPAP, it is not possible to mask which CPAP device the subject is supported by, but the participant, care provider, and outcomes assessor will be masked to whether the subject was randomized to arm A (the device the lung physiology assessment deemed superior for that subject) or arm B (random assignment to the CPAP device, not taking into account the subject's lung physiology).
Allocation
Randomized
Enrollment
20 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Randomization to CPAP with higher change of impedance as measured by EIT. "Arm A-1"
Arm Type
Experimental
Arm Description
After comparing change of impedance as measured by electrical impedance tomography while supported on RAM cannula ventilator CPAP versus occlusive interface bubble CPAP, the participants in this arm are placed on the CPAP that had a greater change of impedance (or less pressure rate product as measured by the esophageal balloon manometry if the change of impedance between the two CPAP modalities are clinically similar). In this Arm A-1, these subjects had higher change in impedance while supported on RAM cannula ventilator CPAP
Arm Title
Randomization to CPAP with higher change of impedance as measured by EIT. "Arm A-2"
Arm Type
Experimental
Arm Description
After comparing change of impedance as measured by electrical impedance tomography while supported on RAM cannula ventilator CPAP versus occlusive interface bubble CPAP, the participants in this arm are placed on the CPAP that had a greater change of impedance (or less pressure rate product as measured by the esophageal balloon manometry if the change of impedance between the two CPAP modalities are clinically similar). In this Arm A-2, these subjects had higher change in impedance while supported on occlusive mask bubble CPAP
Arm Title
Randomization to standard of care - a 'one size fits all' approach. "Arm B-1"
Arm Type
Active Comparator
Arm Description
Currently, the approach to which CPAP modality is chosen for these newborns is defaulted to the preferred CPAP of the Neonatal Intensive Care Unit (NICU) where the newborn is hospitalized. In this Arm B-1, these subjects are randomized 1:1 to RAM cannula ventilator CPAP
Arm Title
Randomization to standard of care - a 'one size fits all' approach. "Arm B-2"
Arm Type
Active Comparator
Arm Description
Currently, the approach to which CPAP modality is chosen for these newborns is defaulted to the preferred CPAP of the NICU where the newborn is hospitalized. In this Arm B-2, these subjects are randomized 1:1 to occlusive mask bubble CPAP
Intervention Type
Device
Intervention Name(s)
RAM cannula ventilator CPAP
Intervention Description
RAM cannula ventilator CPAP
Intervention Type
Device
Intervention Name(s)
Occlusive interface bubble CPAP
Intervention Description
Occlusive interface bubble CPAP
Primary Outcome Measure Information:
Title
change in electrical impedance
Description
change in average electrical impedance with each CPAP delivery modality
Time Frame
2.5 hours during the lung physiology assessment
Title
duration of CPAP treatment
Description
compare groups Arm A-1, A-2 vs Arm B-1, B2; Compare groups Arm A-1, B-1 vs Arm A-2, B-2
Time Frame
through study completion, an average of 2 weeks after the lung physiology assessment
Secondary Outcome Measure Information:
Title
lung physiology measurements (exploratory measures during this pilot study, in preparation for a powered larger trial) change in end expiratory lung impedance
Description
change in end expiratory lung impedance (arbitrary units)
Time Frame
2.5 hours during the lung physiology assessment
Title
lung physiology measurements (exploratory measures during this pilot study, in preparation for a powered larger trial) vascular pulsatility
Description
vascular pulsatility (arbitrary units)
Time Frame
2.5 hours during the lung physiology assessment
Title
lung physiology measurements (exploratory measures during this pilot study, in preparation for a powered larger trial) tidal volume
Description
tidal volume (in milliliters) per weight (in kilograms)
Time Frame
2.5 hours during the lung physiology assessment
Title
lung physiology measurements (exploratory measures during this pilot study, in preparation for a powered larger trial) change in minute ventilation
Description
change in minute ventilation (mL/minute)
Time Frame
2.5 hours during the lung physiology assessment
Title
lung physiology measurements (exploratory measures during this pilot study, in preparation for a powered larger trial) change in dynamic compliance
Description
change in dynamic compliance (mL/cmH2O)
Time Frame
2.5 hours during the lung physiology assessment
Title
lung physiology measurements (exploratory measures during this pilot study, in preparation for a powered larger trial) Respiratory rate
Description
Respiratory rate (breaths per minute)
Time Frame
2.5 hours during the lung physiology assessment
Title
lung physiology measurements (exploratory measures during this pilot study, in preparation for a powered larger trial) Oxygen saturation
Description
Oxygen saturation (percentage)
Time Frame
2.5 hours during the lung physiology assessment
Title
lung physiology measurements (exploratory measures during this pilot study, in preparation for a powered larger trial) Abdominal circumference
Description
Abdominal circumference (cm)
Time Frame
2.5 hours during the lung physiology assessment
Title
lung physiology measurements (exploratory measures during this pilot study, in preparation for a powered larger trial) esophageal pressure change
Description
esophageal pressure change (mm Hg)
Time Frame
2.5 hours during the lung physiology assessment
Title
lung physiology measurements (exploratory measures during this pilot study, in preparation for a powered larger trial) end expiratory pressure
Description
end expiratory pressure via esophageal balloon manometry (mm Hg)
Time Frame
2.5 hours during the lung physiology assessment
Title
lung physiology measurements (exploratory measures during this pilot study, in preparation for a powered larger trial) pressure rate product
Description
pressure rate product (cm H2O / min)
Time Frame
2.5 hours during the lung physiology assessment
Title
clinical outcomes of different CPAP modalities (exploratory measures during this pilot study, in preparation for a powered larger trial) Frequency of deviation
Description
frequency of deviation from assigned CPAP treatment (percentage)
Time Frame
through study completion, an average of 2 weeks after the lung physiology assessment
Title
clinical outcomes of different CPAP modalities (exploratory measures during this pilot study, in preparation for a powered larger trial) frequency of exogenous surfactant administration
Description
frequency of exogenous surfactant administration (percentage)
Time Frame
through study completion, an average of 2 weeks after the lung physiology assessment
Title
clinical outcomes of different CPAP modalities (exploratory measures during this pilot study, in preparation for a powered larger trial)
Description
respiratory support settings if deviated from assigned CPAP treatment (percentage)
Time Frame
through study completion, an average of 2 weeks after the lung physiology assessment

10. Eligibility

Sex
All
Minimum Age & Unit of Time
12 Hours
Maximum Age & Unit of Time
36 Hours
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: medically stable neonates born >32 0/7 weeks and < 37 0/7 weeks gestational age, with birth weights > 1500 grams, are chronologically 12-36 hours old, and are receiving RAM cannula ventilator CPAP with positive end expiratory pressure (PEEP) between 5-6 cm water (H2O) and Fraction of inspired oxygen (FiO2) < 0.3 for the suspected diagnosis of respiratory distress syndrome Exclusion Criteria: neonates with congenital anomalies that potentially will affect respiratory physiology, for example hypoplastic lungs or gastroschisis. neonates with contraindications for wearing an occlusive interface, for example epidermolysis bullosa which may have risk of worsening skin integrity at the pressure points of the occlusive interface, or a known small air leak that may potentially develop into a large pneumothorax. neonates with contraindications for placement of esophageal balloon manometry, for example hypoglycemia managed with extended feeding times greater than 30 minutes. neonates with contraindications for electrical impedance tomography, for example inability to ensure contact of the electrodes on the belt with the skin on the circumference of the chest due to presence of a chest tube dressing.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Jessica E Shui, MD
Phone
617-724-5994
Email
jshui@mgh.harvard.edu
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Jessica E Shui, MD
Organizational Affiliation
Massachusetts General Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
Massachusetts General Hospital
City
Boston
State/Province
Massachusetts
ZIP/Postal Code
02114
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Jessica E Shui, MD
Phone
617-724-5994
Email
jshui@mgh.harvard.edu

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
37009665
Citation
Prakash R, De Paoli AG, Davis PG, Oddie SJ, McGuire W. Bubble devices versus other pressure sources for nasal continuous positive airway pressure in preterm infants. Cochrane Database Syst Rev. 2023 Mar 31;3(3):CD015130. doi: 10.1002/14651858.CD015130.
Results Reference
background
PubMed Identifier
36374241
Citation
Prakash R, De Paoli AG, Oddie SJ, Davis PG, McGuire W. Masks versus prongs as interfaces for nasal continuous positive airway pressure in preterm infants. Cochrane Database Syst Rev. 2022 Nov 14;11(11):CD015129. doi: 10.1002/14651858.CD015129.
Results Reference
background
PubMed Identifier
30567774
Citation
Green EA, Dawson JA, Davis PG, De Paoli AG, Roberts CT. Assessment of resistance of nasal continuous positive airway pressure interfaces. Arch Dis Child Fetal Neonatal Ed. 2019 Sep;104(5):F535-F539. doi: 10.1136/archdischild-2018-315838. Epub 2018 Dec 19.
Results Reference
background
PubMed Identifier
11158463
Citation
Courtney SE, Pyon KH, Saslow JG, Arnold GK, Pandit PB, Habib RH. Lung recruitment and breathing pattern during variable versus continuous flow nasal continuous positive airway pressure in premature infants: an evaluation of three devices. Pediatrics. 2001 Feb;107(2):304-8. doi: 10.1542/peds.107.2.304.
Results Reference
background
PubMed Identifier
35931651
Citation
Nascimento MS, do Prado C, Costa ELV, Alcala GC, Correa LC, Rossi FS, Amato MBP, Rebello CM. Effect of flow rate on the end-expiratory lung volume in infants with bronchiolitis using high-flow nasal cannula evaluated through electrical impedance tomography. Pediatr Pulmonol. 2022 Nov;57(11):2681-2687. doi: 10.1002/ppul.26082. Epub 2022 Aug 17.
Results Reference
background
PubMed Identifier
12910583
Citation
Seddon PC, Davis GM. Validity of esophageal pressure measurements with positive end-expiratory pressure in preterm infants. Pediatr Pulmonol. 2003 Sep;36(3):216-22. doi: 10.1002/ppul.10284.
Results Reference
background
PubMed Identifier
28545875
Citation
Bhatia R, Davis PG, Tingay DG. Regional Volume Characteristics of the Preterm Infant Receiving First Intention Continuous Positive Airway Pressure. J Pediatr. 2017 Aug;187:80-88.e2. doi: 10.1016/j.jpeds.2017.04.046. Epub 2017 May 22.
Results Reference
background

Learn more about this trial

Comparing Different Delivery Systems of Continuous Positive Airway Pressure in Neonates

We'll reach out to this number within 24 hrs